|
|
Advances in Lipid Management - Part 2: Treatment and Management of Dyslipidemias
Webinar #2 in a Series of 3
|
|
Facebook
LinkedIn
E-Mail
|
(10453)
Other: Assessment, Billing and Coding, Cardiometabolic, Cardiovascular, Certificate, Diagnosis, Diagnostic Tests, Dyslipidemia, Evaluation (Follow-up), Hypercholesterolemia, Laboratory Interpretation, Lipids, Metabolic Syndrome, Planning, Primary Care, Screening, Treatment, Treatment Plan
(show less)
|
Released: 10/05/2023
Expires: 11/30/2024 (subject to change) - CE for this activity will not be available after this date.
 | This activity includes closed captioning. |
Webinar Date and Time: 10/25/2023 from 1:00-1:50 PM CTOnDemand Viewing Now Available!
Overview
Did you know that less than half of patients who have severely elevated cholesterol levels receive appropriate treatment, placing them at high risk for CVD and death? A ten percent reduction in cholesterol levels decreases the risk of cardiovascular events, including death, by thirty percent. Join expert faculty Drs. Allison Dimsdale and Colleen Walsh-Irwin for the second of a three-webinar series to learn about lifestyle interventions, lipid-lowering therapies, treatment guidelines and helpful resources.
Objectives- Utilize risk assessment tools and laboratory test results to establish treatment goals.
- Distinguish among the lipid-lowering pharmaceutical treatments.
- Develop evidence-based treatment plans for patients with dyslipidemias.
Speakers
Dr. Allison Dimsdale, DNP, NP-C, AACC, FAANP
Dr. Colleen Walsh-Irwin, DNP, RN, ANP-BC, AACC, EBP-C, FAANP
Disclosure
This program was planned in accordance with AANP CE Standards and Policies.
Speaker Disclosures:
- Dr. Allison Dimsdale has no relevant financial relationships to disclose.
- Dr. Colleen Walsh-Irwin has no relevant financial relationships to disclose.
All Planners involved in this activity have no relevant financial relationships to disclose. This program is supported by an educational grant from Novartis.
Disclaimer
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions- Read this activity description, including objectives and disclosures.
- Complete the Pretest associated to the activity.
- Complete the educational content completely:
- Webinar Presentation: Attend the live webinar or watch the recorded on-demand video of the webinar.
- Review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
- After completing all content, click on the blue Next Steps button:
- Complete the post-test.
- Submit the evaluation to receive full AANP CE/Rx credit.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1 Contact Hour(s) of CE,
0.9 of which may be applied towards Pharmacology
|
|
|
|
Adding Registration, Please wait...
